AlphaFold predicted structure
MED25 · Q71SY5

Mean pLDDT
62.5/ 100
Low
747 residues
Confidence breakdown
- Very high(≥ 90)25%
- Confident(70–90)19%
- Low(50–70)8%
- Very low(< 50)48%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
mediator complex subunit 25
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Clefting
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalCorneal abnormalities
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalcongenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome
neurodegenerative disease
Charcot-Marie-Tooth disease type 2B2
hereditary disease
Tip-toe gait
Charcot-Marie-Tooth disease type 2
syndromic intellectual disability
autosomal recessive non-syndromic intellectual disability
Neurodevelopmental delay
neurodevelopmental disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Mediator of RNA polymerase II transcription subunit 9
Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors
MED25 · Q71SY5

Mean pLDDT
62.5/ 100
Low
747 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0